Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISLAND: Imaging Biomarker for Depression Treatment Stratification
NCT02137369Phase 4Completed
- Sponsor
- Emory University
- Start
- Sep 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram, sertraline in major depressive disorder (MDD), sponsored by Emory University. Started Sep 2014; status: completed.
02
Drugs
escitalopramsertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02137369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137369.